[1] Liver Failure and Artificial Liver Group,Chinese Society of Infectious Diseases,Chinese Medical Association; Severe Liver Disease and Artificial Liver Group,Chinese Society of Hepatology,Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol,2019,35(1):38-44.(in Chinese)中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)[J].临床肝胆病杂志,2019,35(1):38-44.
|
[2] ZHOU XQ. New techniques for the treatment of severe hepatitis[M]. Beijing:Wilitary Science Publishing House,2002:21.(in Chinese)周霞秋.重型肝炎治疗新技术[M].北京:人民军医出版社,2002:21.
|
[3] TIAN YQ,ZHOU N,JIANG YF. Curative efficacy of granulocyte colony-stimulating factor in combination with entecavir in patients with hepatitis B virus related acute-on-chronic liver failure at early stage and its influences on levels of AngⅡ,TNF-α,and IL-10[J]. China Med Herald,2018,15(17):139-142.(in Chinese)田玉球,周宁,蒋永芳.粒细胞集落刺激因子联合恩替卡韦治疗早期乙肝慢加急性肝衰竭的效果及对AngⅡ、TNF-α和IL-10的影响[J].中国医药导报,2018,15(17):139-142.
|
[4] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
|
[5] Chinese Society of Hepatology,Chinese Medical Association.Guidelines on the management of hepatic encephalopathy in cirrhosis[J]. J Clin Hepatol,2018,34(10):2076-2089.(in Chinese)中华医学会肝病分学会.肝硬化肝性脑病诊疗指南[J].临床肝胆病杂志,2018,34(10):2076-2089.
|
[6] KAMATH PS,WIESNER RH,MALINCHOC M,et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology,2001,33(2):464-470.
|
[7] WU TZ,LI J,SHAO L,et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-onchronic liver failure[J]. Gut,2018,67(12):2181-2191.
|
[8] SARIN SK,KEDARISETTY CK,ABBAS Z,et al. Acute-onchronic liver failure:Consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL)2014[J]. Hepatol Int,2014,8(4):453-471.
|
[9] LIU J,BAI FY,ZHANG J. Research advances in diagnostic criteria for acute-on-chronic liver failure and models for prognostic evaluation[J]. J Clin Hepatol,2019,35(6):1384-1387.(in Chinese)刘娟,白飞云,张晶.慢加急性肝衰竭的诊断标准比较及预后判断模型进展[J].临床肝胆病杂志,2019,35(6):1384-1387.
|
[10] CHEN W,YOU J,CHEN J,et al. Modified model for endstage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure[J]. World J Gastroenterol,2017,23(40):7303-7309.
|
[11] ANGELI P,WONG F,WATSON H,et al. Hyponatremia in cirrhosis:Results of a patient population survey[J]. Hepatology,2006,44(6):1535-1542.
|
[12] WANG X,WANG L. Clinical analysis of elderly hyponatremia[J]. Chin J Geriatr,2017,36(4):447-449.(in Chinese)王霞,王翎.老年人低钠血症临床分析[J].中华老年医学杂志,2017,36(4):447-449.
|
[13] NI XZ,WU ZY,CHEN ZP,et al. Expression of ET-1 mRNA in the lung of hepatopulmonary syndrome rats[J]. Chin J Surg,2002,40(2):142-145.(in Chinese)倪醒之,吴志勇,陈治平,等.内皮素-1 mRNA在肝肺综合征大鼠肺组织中表达的研究[J].中华外科杂志,2002,40(2):142-145.
|
[14] ZHANG JL,YANG WL,HU BQ,et al. Endothelin-1 activation of the endothelin B receptor modulates pulmonary endothelial CX3CL1 and contributes to pulmonary angiogenesis in experimental hepatopulmonary syndrome[J]. Am J Pathol,2014,184(6):1706-1714.
|
[15] TONG JJ,ZHAO W,MU XY,et al. Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure[J].Chin Med J(Engl),2019,132(13):1541-1549.
|
[16] MALINCHOC M,KAMATH P S,GORDON F D,et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology,2000,31(4):864-871.
|
[17] CAI XJ,SHEN J,ZHU XH,et al. Evaluation of integrated model for end-stage liver disease model in predicting prognosis of acute-on-chronic liver failure and the choice of treatment[J/CD]. Chin J Exp Clin Infect Dis(Electronic Edition),2018,12(5):446-452.(in Chinese)蔡晓娟,沈毅,朱晓红,等.整合终末期肝病模型在慢加急性肝功能衰竭预后判断及治疗中的应用[J/CD].中华实验和临床感染病杂志(电子版),2018,12(5):446-452.
|
[18] GYORI GP,SILBERHUMER GR,RAHMEL A,et al. Impact of dynamic changes in MELD score on survival after liver transplantation-a Eurotransplant registry analysis[J]. Liver Int,2016,36(7):1011-1017.
|
[19] European Association for the Study of the Liver. EASL clinical practice guidelines:Liver transplantation[J]. J Hepatol,2016,64(2):433-485.
|
[20] ZHANG DJ,ZHOU B,HOU JL. Research progress in prognostic models of acute-on-chronic liver failure[J]. J Clin Hepatol,2018,34(6):1351-1356.张东敬,周彬,侯金林.慢加急性肝衰竭预后模型的研究进展[J].临床肝胆病杂志,2018,34(6):1351-1356.
|